HomeProduct Newsletter Vitamins China E-News

Vitamins China E-News

Publication: Monthly on the
Published by CCM

Vitamins China E-News provides you with real-time intelligence on China's vitamins market.
 
China is the world's largest exporter of vitamins, while the domestic market has also expanded rapidly in recent years thanks to growing demand from the feed and pharmaceuticals markets. Now, competition in the industry is shifting from producing API to higher-margin pharmaceutical-grade products, while China’s tougher stance on environmental protection is also having an effect.
 
Vitamins China E-News will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire vitamins industry chain, from raw materials to end consumption. This includes:
      
  • Breaking news from China and abroad
    •   
  • The latest market data, including price information for raw materials, intermediates and end products, import/export data, production, consumption, operating rates, etc.
    •   
  • In-depth analysis of market trends, Chinese government policy, the performance of leading Chinese producers, M&A, new technologies, and more
    •   
  • Expert commentary from industry insiders, including regular guest articles and interviews with insiders at leading Chinese manufacturers, associations and government organizations
Vitamins China E-News is also available as a monthly newsletter, which can be downloaded in PDF format. For more information, you can download a free sample below, or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.

www.cnchemicals.com www.cnchemicals.com

  • Future-issues subscription

Starting from the issue of
202407
lasting for


0.5 1 1.5 2 2.5 3


year(s)  , is priced at


  • Single user license:
    USD 2,950.00
  • Corporate license:
    USD 7,375.00

All the prices on this website exclude VAT.
<<
  • 202407
  • 202406
  • 202405
  • 202404
  • 202403
  • 202402
  • 202401
  • 202312
  • 202311
  • 202310
  • 202309
  • 202308
  • 202307
  • 202306
  • 202305
  • 202304
  • 202303
  • 202302
  • 202301
  • 202212
  • 202211
  • 202210
  • 202209
  • 202208
  • 202207
  • 202206
  • 202205
  • 202204
  • 202203
  • 202202
  • 202201
  • 202112
  • 202111
  • 202110
  • 202109
  • 202108
  • 202107
  • 202106
  • 202105
  • 202104
  • 202103
  • 202102
  • 202101
  • 202012
  • 202011
  • 202010
  • 202009
  • 202008
  • 202007
  • 202006
  • 202005
  • 202004
  • 202003
  • 202002
  • 202001
  • 201912
  • 201911
  • 201910
  • 201909
  • 201908
  • 201907
  • 201906
  • 201905
  • 201904
  • 201903
  • 201902
  • 201901
  • 201812
  • 201811
  • 201810
  • 201809
  • 201808
  • 201807
  • 201806
  • 201805
  • 201804
  • 201803
  • 201802
  • 201801
  • 201712
  • 201711
  • 201710
  • 201709
  • 201708
  • 201707
  • 201706
  • 201705
  • 201704
  • 201703
  • 201702
  • 201701
  • 201612
  • 201611
  • 201610
  • 201609
  • 201608
  • 201607
  • 201606
  • 201605
  • 201604
  • 201603
  • 201602
  • 201601
  • 201512
  • 201511
  • 201510
  • 201509
  • 201508
  • 201507
  • 201506
  • 201505
  • 201504
  • 201503
  • 201502
  • 201501
  • 201412
  • 201411
  • 201410
>>

Main Content of Vitamins China E-News 201912

Price of this issue :
USD 98

Published on 26th December, 2019

Published on 26th December, 2019

In December 2019, domestic vitamin market was boosted under the stimulation of several factors. The prices of vitamin B7, vitamin E, nicotinamide, calcium pantothenate and vitamin K3 had increased significantly.

Published on 26th December, 2019

On 16 December, the EIA report of Haixin Pharmaceutical's upgrading project of vitamin series products production lines was made public. This project is divided into two phases, and in the Phase II, the production capacity of 3,000 t/a vitamin series products will be set.

Published on 25th December, 2019

The Aosa Pharmaceutical Industrial Park project of Shenzhen Aosa is being constructed intensely. The supporting facilities have been installed and the test run of the equipment has been completed. The entire park is expected to enter into the production in early 2020.

Published on 25th December, 2019

On 2 December, the EIA report of Luwei Pharmaceutical's 40,000 t/a sodium ascorbate/calcium ascorbate project and 30,000 t/a L-Ascorbic acid-2-phosphate project was made public in the company's homepage. It is an expansion project with a total investment of USD42.70 million (RMB300.00 million).

Published on 25th December, 2019

On 25 November, Anhui Huilong replied to CSRC's feedback on the company's intention to buy a 100% stake in Haihua Technology and disclosed the production and operation condition of Haihua Technology's m-cresol business.

Published on 18th December, 2019

Published on 18th December, 2019

Published on 16th December, 2019

On 6 December, Guangxi Hechi announced that CSRC would convene a meeting on 11 December to examine the company's material assets reorganisation. The contents of reorganisation include the sale of the real assets of urea production as well as the acquisition of a 93.41% stake in Nansong Chemi-tech.

Published on 13th December, 2019

Published on 12th December, 2019

In October 2019, China exported 16,820.80 tonnes of vitamins, falling by 4.00% compared with 17,522.19 tonnes in September 2019. The export volume of VA hit the lowest point of the ten months of the year.

Published on 12th December, 2019

On 2 December, SAMR issued the Catalogue of the Raw Materials of Nutrient Supplement Health Foods (Draft for Comments) (2019 Edition) and Catalogue of the Health Functions Allowed to be Claimed in Nutrient Supplement Health Foods (Draft for Comments) (2019 Edition).

Published on 12th December, 2019

Published on 9th December, 2019

Published on 9th December, 2019

Published on 9th December, 2019

Published on 9th December, 2019

Published on 9th December, 2019

At the end of November, Guangji Pharmaceutical responded to the feedback from CSRC on Guangji Pharmaceutical's application for non-public offering of shares.

Published on 9th December, 2019

Published on 6th December, 2019

In late November, Brother Enterprises announced that it intended to merge the two wholly-owned subsidiaries, namely Brother Vitamins and Dafeng Brother.

Published on 5th December, 2019

Published on 5th December, 2019

CCM Customized Service on Market Research

Do you want Import & Export Analysis, Financial Data, Cost Analysis, Supply Chain Research etc. ? We will customize the specific research for you, in case the services listed above does not meet your precise requirements. Our product and industry research in China’s agriculture, chemicals, food & ingredients and life science markets will comprehensively cover the business information, which is able to help you arrive at strategic and profitable business decisions.

Please directly contact econtact@cnchemicals.com to specify your Market Research Requirement